Activation of Rho kinase by TNF-α is required for JNK activation in human pulmonary microvascular endothelial cells

Journal of Immunology

Volumn 180, Issue 1, 2008, Pages 550-558

  Mong, Phyllus Y ^a   Petrulio, Christian ^a   Kaufman, Howard L ^a   Wang, Qin ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; INTERLEUKIN 6; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; AMIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PYRIDINE DERIVATIVE;

ARTICLE; CELL ACTIVATION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSKELETON; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG ENDOTHELIUM; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; CAPILLARY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; VASCULAR ENDOTHELIUM; VASCULARIZATION;

AMIDES; CAPILLARIES; ENDOTHELIUM, VASCULAR; HUMANS; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG; MAP KINASE KINASE 4; PNEUMONIA; PYRIDINES; RHO-ASSOCIATED KINASES; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40449087466     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.1.550     Document Type: Article

References (53)

1. Garg, A. K., and B. B. Aggarwal. 2002. Reactive oxygen intermediates in TNF signaling. Mol. Immunol. 39: 509-517.
2. Baud, V., and M. Karin. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11: 372-377.
3. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10: 45-65.
4. Chen, G., and D. V. Goeddel. 2002. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635.
5. 2-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol. Cell. Biol. 23: 2871-2882.
6. Arndt, P. G., S. K. Young, J. G. Lieber, M. B. Fessler, J. A. Nick, and G. S. Worthen. 2005. Inhibition of c-Jun N-terminal kinase limits lipopolysaccharide-induced pulmonary neutrophil influx. Am. J. Respir. Crit. Care Med. 171: 978-986.
7. Arndt, P. G., S. K. Young, and G. S. Worthen. 2005. Regulation of lipopolysaccharide-induced lung inflammation by plasminogen activator Inhibitor-1 through a JNK-mediated pathway. J. Immunol. 175: 4049-4059.
8. Ferrero, E., M. R. Zocchi, E. Magni, M. C. Panzeri, F. Curnis, C. Rugarli, M. E. Ferrero, and A. Corti. 2001 Roles of tumor necrosis factor p55 and p75 receptors in TNF-α-induced vascular permeability. Am. J. Physiol. 281: C1173-C1179.
9. Pan, S., P. An, R. Zhang, X. He, G. Yin, and W. Min. 2002. Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis. Mol. Cell. Biol. 22: 7512-7523.
10. Zhao, Y., D. B. Conze, J. A. Hanover, and J. D. Ashwell. 2007. Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-dependent ASK1 ubiquitination and terminates mitogen-activated protein kinase signaling. J. Biol. Chem. 282: 7777-7782.
11. Ventura, J. J., A. Hubner, C. Zhang, R. A. Flavell, K. M. Shokat, and R. J. Davis. 2006. Chemical genetic analysis of the time course of signal transduction by JNK. Mol. Cell. 21: 701-710.
12. Hunter, I., and G. F. Nixon. 2006. Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells: lipid rafts are essential for TNF-α-mediated activation of RhoA but dispensable for the activation of the NF-κB and MAPK pathways. J. Biol. Chem. 281: 34705-34715.
13. Dovas, A., and J. R. Couchman. 2005. RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem. J. 390: 1-9.
14. Burridge, K., and K. Wennerberg. 2004. Rho and Rac take center stage. Cell 116: 167-179.
15. Takai, Y., T. Sasaki, and T. Matozaki. 2001. Small GTP-binding proteins. Physiol. Rev. 81: 153-208.
16. Petrache, I., A. D. Verin, M. T. Crow, A. Birukova, F. Liu, and J. G. Garcia. 2001 Differential effect of MLC kinase in TNF-α-induced endothelial cell apoptosis and barrier dysfunction. Am. J. Physiol. 280: L1168-L1178.
17. Tasaka, S., H. Koh, W. Yamada, M. Shimizu, Y. Ogawa, N. Hasegawa, K. Yamaguchi, Y. Ishii, S. E. Richer, C. M. Doerschuk, and A. Ishizaka. 2005. Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor: Y-27632. Am. J. Respir. Cell. Mol. Biol. 32: 504-510.
18. Loirand, G., P. Guerin, and P. Pacaud. 2006. Rho kinases in cardiovascular physiology and pathophysiology. Circ. Res. 98: 322-334.
19. Marinissen, M. J., M. Chiariello, T. Tanos, O. Bernard, S. Narumiya, and J. S. Gutkind. 2004. The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis. Mol. Cell. 14: 29-41.
20. Jaffe, A. B., A. Hall, and A. Schmidt. 2005. Association of CNK1 with Rho guanine nucleotide exchange factors controls signaling specificity downstream of Rho. Curr. Biol. 15: 405-412.
21. Koss, M., G. R. Pfeiffer, 2nd, Y. Wang, S. T. Thomas, M. Yerukhimovich, W. A. Gaarde, C. M. Doerschuk, and Q. Wang. 2006. Ezrin/radixin/moesin proteins are phosphorylated by TNF-α and modulate permeability increases in human pulmonary microvascular endothelial cells. J. Immunol. 176: 1218 -1227.
22. Kawkitinarong, K., L. Linz-McGillem, K. G. Birukov, and J. G. Garcia. 2004. Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am. J. Respir. Cell. Mol. Biol. 31: 517-527.
23. Ohtsu, H., M. Mifune, G. D. Frank, S. Saito, T. Inagami, S. Kim-Mitsuyama, Y. Takuwa, T. Sasaki, J. D. Rothstein, H. Suzuki, et al. 2005. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 25: 1831-1836.
24. Nishida, M., S. Tanabe, Y. Maruyama, S. Mangmool, K. Urayama, Y. Nagamatsu, S. Takagahara, J. H. Turner, T. Kozasa, H. Kobayashi, et al. 2005. G α 12/13- and reactive oxygen species-dependent activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase by angiotensin receptor stimulation in rat neonatal cardiomyocytes. J. Biol. Chem. 280: 18434-18441.
25. Miho, N., T. Ishida, N. Kuwaba, M. Ishida, K. Shimote-Abe, K. Tabuchi, T. Oshima, M. Yoshizumi, and K. Chayama. 2005. Role of the JNK pathway in thrombin-induced ICAM-1 expression in endothelial cells. Cardiovasc. Res. 68: 289-298.
26. Zhang, X. P., and T. H. Hintze. 2006. cAMP signal transduction induces eNOS activation by promoting PKB phosphorylation. Am. J. Physiol. 290: H2376-H2384.
27. Kimura, K., M. Ito, M. Amano, K. Chihara, Y. Fukata, M. Nakafuku, B. Yamamori, J. Feng, T. Nakano, K. Okawa, et al. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248.
28. Amano, M., M. Ito, K. Kimura, Y. Fukata, K. Chihara, T. Nakano, Y. Matsuura, and K. Kaibuchi. 1996. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271: 20246-20249.
29. Kureishi, Y., S. Kobayashi, M. Amano, K. Kimura, H. Kanaide, T. Nakano, K. Kaibuchi, and M. Ito. 1997. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J. Biol. Chem. 272: 12257-12260.
30. Ito, M., T. Nakano, F. Erdodi, and D. J. Hartshorne. 2004. Myosin phosphatase: structure, regulation and function. Mol. Cell. Biochem. 259: 197-209.
31. Li, Z., X. Dong, Z. Wang, W. Liu, N. Deng, Y. Ding, L. Tang, T. Hla, R. Zeng, L. Li, and D. Wu. 2005. Regulation of PTEN by Rho small GTPases. Nat. Cell. Biol. 7: 399-404.
32. Cully, M., H. You, A. J. Levine, and T. W. Mak. 2006. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6: 184-192.
33. Wu, K. K. 2002. Regulation of endothelial nitric oxide synthase activity and gene expression. Ann. NY Acad. Sci. 962: 122-130.
34. Ming, X. F., H. Viswambharan, C. Barandier, J. Ruffieux, K. Kaibuchi, S. Rusconi, and Z. Yang. 2002. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol. Cell. Biol. 22: 8467-8477.
35. Park, H. S., S. H. Huh, M. S. Kim, S. H. Lee, and E. J. Choi. 2000. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc. Natl. Acad. Sci. USA 97: 14382-14387.
36. Park, H. S., S. H. Huh, M. S. Kim, D. Y. Kim, B. J. Gwag, S. G. Cho, and E. J. Choi. 2006. Neuronal nitric oxide synthase (nNOS) modulates the JNK1 activity through redox mechanism: a cGMP independent pathway. Biochem. Biophys. Res. Commun. 346: 408-414.
37. Beard, K. M., H. Lu, K. Ho, and I. G. Fantus. 2006. Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of Jun NH2-terminal kinase. Diabetes 55: 2678-2687.
38. L. Exp. Cell. Res. 298: 632-642.
39. Wicovsky, A., N. Muller, N. Daryab, R. Marienfeld, C. Kneitz, S. Kavuri, M. Leverkus, B. Baumann, and H. Wajant. 2007. Sustained JNK activation in response to TNF is mediated by caspases in a cell type-specific manner. J. Biol. Chem. 282: 2174-2183.
40. Yeh, W. C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J. L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, et al. 1997. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715-725.
41. Kamata, H., S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin. 2005. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661.
42. Tobiume, K., A. Matsuzawa, T. Takahashi, H. Nishitoh, K. Morita, K. Takeda, O. Minowa, K. Miyazono, T. Noda, and H. Ichijo. 2001. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2: 222-228.
43. Nakajima, A., S. Komazawa-Sakon, M. Takekawa, T. Sasazuki, W. C. Yeh, H. Yagita, K. Okumura, and H. Nakano. 2006. An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway. EMBO J. 25: 5549-5559.
44. Pham, C. G., C. Bubici, F. Zazzeroni, S. Papa, J. Jones, K. Alvarez, S. Jayawardena, E. De Smaele, R. Cong, C. Beaumont, et al. 2004. Ferritin heavy chain upregulation by NF-κB inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell 119: 529-542.
45. Sakon, S., X. Xue, M. Takekawa, T. Sasazuki, T. Okazaki, Y. Kojima, J. H. Piao, H. Yagita, K. Okumura, T. Doi, and H. Nakano. 2003. NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J. 22: 3898-3909.
46. Ventura, J. J., P. Cogswell, R. A. Flavell, A. S. Baldwin, Jr., and R. J. Davis. 2004. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev. 18: 2905-2915.
47. Tournier, C., C. Dong, T. K. Turner, S. N. Jones, R. A. Flavell, and R. J. Davis. 2001. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. 15: 1419-1426.
48. Wang, X., A. Destrument, and C. Tournier. 2007. Physiological roles of MKK4 and MKK7: Insights from animal models. Biochim. Biophys. Acta 1773: 1349-1357.
49. Yang, D., C. Tournier, M. Wysk, H. T. Lu, J. Xu, R. J. Davis, and R. A. Flavell. 1997. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. USA 94: 3004-3009.
50. Wada, T., N. Joza, H. Y. Cheng, T. Sasaki, I. Kozieradzki, K. Bachmaier, T. Katada, M. Schreiber, E. F. Wagner, H. Nishina, and J. M. Penninger. 2004. MKK7 couples stress signaling to G2/M cell-cycle progression and cellular senescence. Nat. Cell. Biol. 6: 215-226.
51. Zou, H., Q. Li, S. C. Lin, Z. Wu, J. Han, and Z. Ye. 2007. Differential requirement of MKK4 and MKK7 in JNK activation by distinct scaffold proteins. FEBS Lett. 581: 196-202.
52. 536 nuclear factor κB/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Circ. Res. 99: 723-730.
53. Jones, M. R., L. J. Quinton, B. T. Simms, M. M. Lupa, M. S. Kogan, and J. P. Mizgerd. 2006. Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia. J. Infect. Dis. 193: 360-369.